Axios Pro Rata: FIFA fallout | Axios Pro Rata Summary

1. Key Themes

Fintech Consolidation Hits a Wall

Stripe and Advent International's abandoned pursuit of PayPal — which "would have been the largest fintech acquisition ever" — signals that mega-fintech M&A faces real pricing friction. PayPal's stock immediately dropped 12%+ after the deal collapsed, opening at $53.74 versus the $60.50/share offer price, suggesting the market had been pricing in a deal premium. Meanwhile, Stripe separately committed $8 billion for AI model marketplace OpenRouter, showing it is prioritizing AI infrastructure over legacy payments scale.

University R&D → Venture-Built Biotech is a Proven Value-Creation Machine

The FDA's approval of a new drug for the most common form of pancreatic cancer illustrates a repeatable playbook: "Revolution Medicines, a Silicon Valley biotech that was essentially created by Third Rock Ventures, based on chemistry research at the University of Illinois." The article draws an explicit parallel to Flagship Pioneering's creation of Moderna. Primack editorializes that both examples "highlight not just the deep value of venture capital, but also of university R&D that's being increasingly threatened by puerile politics." This is a direct investment theme — back firm-built biotechs rooted in academic IP before political headwinds constrain the pipeline.

Private Aviation is a Hot PE Asset Class

Two major private aviation transactions appeared in the same issue: Apollo agreed to acquire Atlantic Aviation "at nearly a $10b valuation from KKR," and Vista Global Holding is "considering a $1b+ European IPO at more than a $10b valuation." The clustering of deals at the $10B mark signals sustained PE conviction in private aviation infrastructure.

Healthcare PE is Bifurcating: Providers Up, Health IT Down

Per Bain & Co. data cited in the issue, first-half 2026 healthcare PE deal activity showed a clear split. "Provider-related transaction value jumped, across a range of subspecialties," while "Health care IT deal activity was hampered by the SaaSpocalypse." Sponsor exits are most concentrated "in areas with clear transformation theses, such as tech-enabled services" — a signal about where the exit market is still functioning.

The Venture-Built Thesis Shift: Beyond Software Engineering

New solo GP Will Robbins articulates an emerging framework for what the next wave of company-building actually requires. "His basic thesis is said to be that software engineering is basically a solved problem for company-building, whereas the future challenges are around things like trust, permissioning and real-world politics." This reflects a broader maturing of the AI-enabled software layer and a pivot toward companies that solve governance, compliance, and real-world integration problems.

2. Contrarian Perspectives

PayPal's Standalone Path May Be Stronger Than the Market Thinks

The consensus reaction to a deal collapse is to sell — and the market obliged, dropping PayPal 12%. But the article subtly reframes this: new CEO Enrique Lores "took over as PayPal's CEO this past March, promising an aggressive turnaround plan that's still more framework than roadmap. It looks like he'll get his chance to flesh it out." The implication is that the deal falling apart may be opportunity rather than disaster — Lores now has the runway to execute without an acquirer's constraints. The price drop may be an overreaction if the turnaround thesis is credible.

Software Engineering Is Now a Commodity Input, Not a Competitive Moat

Robbins' thesis directly challenges the dominant narrative of the past decade: "software engineering is basically a solved problem for company-building, whereas the future challenges are around things like trust, permissioning and real-world politics." If correct, this means that the next defensible startups won't win on technical execution but on navigating regulatory, political, and trust architectures — a very different capability set and investor filter.

University R&D Cuts Are a Systemic Threat to Biotech's Most Productive Pipeline

Primack flags this risk with sharp language: university R&D funding is "being increasingly threatened by puerile politics." Given that Revolution Medicines (Third Rock, University of Illinois) and Moderna (Flagship Pioneering) both trace directly to academic research, any sustained erosion of university R&D funding represents a slow-moving but high-impact threat to the most capital-efficient form of biotech creation — one that the market may not be pricing into long-duration biotech risk.

3. Companies Identified

Stripe

Description: Private payments infrastructure company
Why mentioned: Dropped its $53B pursuit of PayPal alongside Advent International; separately acquired OpenRouter for $8B
Quote: "Stripe and Advent International have dropped their $53 billion pursuit of PayPal... This would have been the largest fintech acquisition ever."

PayPal (Nasdaq: PYPL)

Description: Public payments company
Why mentioned: Target of collapsed Stripe/Advent acquisition; stock dropped 12%+ on deal failure
Quote: "PayPal had been trading just above the $60.50 per share offered by Stripe and Advent, but today opened down more than 12% to $53.74 per share."

OpenRouter

Description: AI model marketplace
Why mentioned: Stripe agreed to pay $8B for it, on an independent track from the PayPal pursuit
Quote: "Stripe last week agreed to pay $8 billion for AI model marketplace OpenRouter."

Revolution Medicines

Description: Silicon Valley biotech focused on RAS-cancer assets
Why mentioned: FDA approved its drug for the most common form of pancreatic cancer; case study in venture-built biotech from academic IP
Quote: "A Silicon Valley biotech that was essentially created by Third Rock Ventures, based on chemistry research at the University of Illinois."

Moderna

Description: Public mRNA biotech
Why mentioned: Parallel case study to Revolution Medicines; both created through venture-firm-led models rooted in university research
Quote: "Flagship Pioneering did something similar with Moderna — which recently made its own blockbuster cancer announcement."

Victory Capital

Description: Asset management firm
Why mentioned: Acquiring First Eagle Investments for ~$7B in stock, generating a strong IRR for seller Genstar Capital (bought for $4B just one year prior)
Quote: "Victory Capital on Wednesday announced an agreement to acquire asset manager First Eagle Investments from Genstar Capital for around $7 billion in stock."

Thrive Eternal (Josh Kushner)

Description: Venture capital firm
Why mentioned: Sought by UEFA via federal subpoena for documents related to FIFA's proposed commercial subsidiary; Kushner is not an anticipated defendant
Quote: "UEFA isn't alleging any wrongdoing against the venture capitalist or his firm, writing that 'neither Thrive nor Kushner is an anticipated defendant.'"

Owner

Description: AI platform for restaurants and small businesses
Why mentioned: Raised $240M at a $2.3B valuation, led by Goldman Sachs
Quote: "Owner, an AI platform for restaurants and small businesses, raised $240m at a $2.3b valuation."

Ramp

Description: Business finance/spend management platform
Why mentioned: Highlighted as a standout investment from Will Robbins' tenure at Contrary (Series B)
Quote: "Robbins' time with Contrary was highlighted by seed checks for Zepto and Corgi, plus the Series B for Ramp."

Atlantic Aviation

Description: Private jet fixed-base operator (Plano, TX)
Why mentioned: Apollo acquiring it from KKR at nearly $10B valuation
Quote: "Apollo agreed to acquire Atlantic Aviation, a Plano, Texas-based private jet fixed-base operator, at nearly a $10b valuation from KKR."

Vista Global Holding

Description: UAE-based private aviation group backed by RRJ Capital
Why mentioned: Considering a $1B+ European IPO at $10B+ valuation
Quote: "Vista Global Holding, a UAE-based private aviation group backed by RRJ Capital, is considering a $1b+ European IPO at more than a $10b valuation."

Linear

Description: SF-based product management tool
Why mentioned: Completed a $99M employee tender at a $2.5B valuation, with participation from Salesforce Ventures and S32
Quote: "Linear, an SF-based product management tool, completed a $99m tender for current and former employees at a $2.5b valuation."

Andreessen Horowitz (a16z)

Description: Major venture capital firm
Why mentioned: Raised $1.1B for its first hardware infrastructure fund — a notable new product category for the firm
Quote: "Andreessen Horowitz raised $1.1b for its first hardware infrastructure fund."

Authentic Brands Group

Description: Brand IP acquirer backed by CVC, General Atlantic, HPS, and Leonard Green
Why mentioned: Acquired IP of Drake's streetwear brand October's Very Own
Quote: "Authentic Brands Group acquired the IP of October's Very Own, a Canadian streetwear and lifestyle brand co-founded by Drake."

Cyclic Materials

Description: Canadian rare-earths recycler
Why mentioned: Raised $75M led by T. Rowe Price — notable for critical materials/sustainability investment theme
Quote: "Cyclic Materials, a Canadian rare-earths recycler, raised US$75m. T. Rowe Price led."

Ajaib

Description: Indonesian online stock trading platform
Why mentioned: Raised $270M Series C from Japan's SBI Holdings — large emerging market fintech round
Quote: "Ajaib, an Indonesian online stock trading platform, raised $270m in Series C funding from Japan's SBI Holdings."

4. People Identified

Josh Kushner

Description: Venture capitalist; founder of Thrive Capital / Thrive Eternal
Why mentioned: UEFA subpoenaed Thrive for documents related to FIFA's proposed commercial subsidiary, which Thrive was set to back. Not accused of wrongdoing.
Quote: "UEFA, Europe's top soccer authority, yesterday asked a federal judge in Manhattan to approve subpoenas for testimony and documents tied to FIFA's proposed creation of a commercial subsidiary that would have been backed by Kushner's Thrive Eternal."

Gianni Infantino

Description: President of FIFA
Why mentioned: UEFA is attempting to build a criminal case against him in Switzerland, using the Thrive/FIFA deal as a potential source of evidence
Quote: "In short, it [UEFA] wants to build a criminal case in Switzerland against FIFA president Gianni Infantino, and thinks some smoking guns might be found via discovery."

Will Robbins

Description: Former General Partner at Contrary; now solo GP founding Robbins Capital
Why mentioned: Quietly departed Contrary after eight years; has already held a first close on his debut fund with a differentiated thesis around trust, permissioning, and real-world politics
Quote: "His basic thesis is said to be that software engineering is basically a solved problem for company-building, whereas the future challenges are around things like trust, permissioning and real-world politics."

Enrique Lores

Description: CEO of PayPal (since March)
Why mentioned: Now must execute a standalone turnaround after the Stripe/Advent deal collapsed
Quote: "Enrique Lores took over as PayPal's CEO this past March, promising an aggressive turnaround plan that's still more framework than roadmap. It looks like he'll get his chance to flesh it out."

5. Operating Insights

The "Software Is Solved" Framing Has Real Fundraising and Hiring Implications

Robbins' thesis — "software engineering is basically a solved problem for company-building, whereas the future challenges are around things like trust, permissioning and real-world politics" — is actionable for operators. Companies that are still competing primarily on engineering talent may be building on yesterday's moat. The next defensible hires are likely policy, compliance, and trust-architecture experts, not engineers alone.

Venture-Built Biotech Requires Tight University IP Sourcing, Not Just Capital

The Revolution Medicines / Third Rock / University of Illinois example demonstrates a replicable creation model. The article explicitly frames university R&D as the upstream source of value — and warns that it is under threat. For biotech operators and investors, the takeaway is to prioritize sourcing from and protecting relationships with university research programs before political disruption further constrains the pipeline. "Both highlight not just the deep value of venture capital, but also of university R&D that's being increasingly threatened by puerile politics."

Healthcare PE Exits Require a "Clear Transformation Thesis"

For operators in healthcare building toward a PE exit, the Bain data makes the bar explicit: sponsor sales were most likely completed "in areas with clear transformation theses, such as tech-enabled services." Companies that cannot articulate a transformation story — even within a strong sector — are facing a harder exit environment, particularly in health IT where the "SaaSpocalypse" has suppressed deal activity.

6. Overlooked Insights

Genstar Capital Doubled Its Money on First Eagle in One Year

Buried in the ROI note: Genstar Capital "paid $4 billion to buy First Eagle last August," and is now selling to Victory Capital for "around $7 billion in stock." That's a ~75% return in roughly 12 months on an asset management acquisition — an unusually fast and strong IRR in a sector not known for rapid value creation. This suggests either significant multiple expansion in asset management M&A or that Genstar timed the entry exceptionally well, and is worth watching as a signal of asset manager valuation trends.

a16z's First Hardware Infrastructure Fund Signals a Major Strategy Expansion

Andreessen Horowitz raising "$1.1b for its first hardware infrastructure fund" is mentioned only as a one-liner in the fundraising section, but it marks a notable category expansion for the firm. Most a16z funds target software, crypto, bio, or growth equity. A dedicated hardware infrastructure vehicle — especially at $1.1B — signals the firm believes physical infrastructure (likely AI compute, data centers, or semiconductor supply chain) is now venture-scale and warrants a dedicated strategy.